Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies
Current Rheumatology Research · 2024
DOI: 10.46439/rheumatology.4.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Rheumatology Research, 2024. Verfasst von Bohong Gao und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Arthritis remains a common and debilitating disease affecting millions of people worldwide. Osteoarthritis (OA) and rheumatoid arthritis (RA) are among the most common forms of this chronic, degenerative disease, which is moving toward precision medicine.
Zitieren
APA
Gao, B., Yin, Z., & Zhang, Y. (2024). Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies. Current Rheumatology Research. https://doi.org/10.46439/rheumatology.4.025
Vancouver
Gao B, Yin Z, Zhang Y. Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies. Current Rheumatology Research. 2024. doi:10.46439/rheumatology.4.025
BibTeX
@article{Gao2024,
author = {Gao, Bohong and Yin, Zhihua and Zhang, Yue},
title = {Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies},
journal = {Current Rheumatology Research},
year = {2024},
doi = {10.46439/rheumatology.4.025}
}
EUVIMED